Evidence map›Paper›PMID 35369633›Full record

ArticlePostepy dermatologii i alergologii2022

The effect of the RadioProtect cosmetic formulation on the skin of oncological patients treated with selected cytostatic drugs and ionizing radiation.

Joanna Igielska-Kalwat, Sława Połoczańska-Godek, Dawid Murawa, Róża Poźniak-Balicka, Małgorzata Wachowiak, Grzegorz Demski, Sławomir Cieśla

Abstract read
In one paragraph

Article in Postepy dermatologii i alergologii, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Joanna Igielska-KalwatSymbiosis Dermatology Center, Poznan Science and Technology Park, Poznan, Poland.
Sława Połoczańska-GodekHigher School of Health, Beauty and Education, Poznan, Poland.
Dawid MurawaDepartment of Surgery and Oncology, Faculty of Medicine and Health Sciences, University of Zielona Gora, Zielona Gora, Poland.
Róża Poźniak-BalickaGeneral and Oncological Surgery Clinic, Karol Marcinkowski University Hospital, Zielona Gora, Poland.
Małgorzata WachowiakGeneral and Oncological Surgery Clinic, Karol Marcinkowski University Hospital, Zielona Gora, Poland.
Grzegorz DemskiAurea Pharma and RadioProtect, Poland.
Sławomir CieślaGeneral and Oncological Surgery Clinic, Karol Marcinkowski University Hospital, Zielona Gora, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: According to the Polish Central Statistical Office and the National Cancer Registry, cancer is the main cause of death in the world. Every year over 8 million people die from cancer worldwide, while in Poland the disease kills nearly 100,000 people. The group of patients analysed in this study suffered from breast, colorectal and lung cancers, and underwent radio- and chemotherapy. The patients were treated with a cosmetic formulation to accelerate the healing of their skin and improve the functioning of the hydrolipidic barrier. Aim: To examine oncological patients' skin and to improve its biophysical parameters with a specialized cosmetic preparation. Material and methods: The study was conducted on 60 female cancer patients treated at the University Hospital in Zielona Gora, Poland. The patients volunteered for Results: The emulsions applied to the patients undergoing chemotherapy significantly increased the hydration of their epidermis. After 4 months of regular use of the preparation, their skin hydration level increased by 22%. The skin hydration of the patients undergoing radiotherapy increased by 3%, as compared with the levels at the beginning of the study. Conclusions: Cosmetic formulations for oncological patients restore the adequate level of skin hydration, aid the reconstruction of the skin and its protective barrier, soothe irritations, accelerate the healing of pathological lesions and prevent their development. Adverse effects may delay or prevent further treatment. Therefore, appropriately tailored care is very important and should not be overlooked.

Indexed as

cytostatic drugshydrolipidic barrierionizing radiationskin hydration

Identifiers

PMID35369633
PMCPMC8953863

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.